AstraZeneca: all 4,196 studies
Page 2 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine CareRecruitingNCT07424261
- CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLCRecruitingNCT07413757
- A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor PatientsRecruitingNCT07404202
- Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube CancerRecruitingNCT07402915Phase 1
- Ravulizumab Outcomes in Polish Patients With aHUSRecruitingNCT07399730
- ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in RussiaRecruitingNCT07399665
- A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous DurvalumabRecruitingNCT07391670Phase 1
- A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)RecruitingNCT07391657Phase 3
- The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in RussiaRecruitingNCT07390240
- Phase 3b Study in Patients With Severe Asthma Treated With TezepelumabRecruitingNCT07363642Phase 3
- Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care SystemRecruitingNCT07361276
- An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.RecruitingNCT07357597Phase 4
- Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN2230 in Healthy ParticipantsRecruitingNCT07352423Phase 1
- A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic ImpairmentRecruitingNCT07343960Phase 1
- Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.RecruitingNCT07330245
- A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in ChinaRecruitingNCT07316062
- Study for Assessing the Prevalence of Airflow Limitation in Outpatients With History of Smoking Attending Cardiology ClinicsRecruitingNCT07315958
- Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUSRecruitingNCT07308574Phase 4
- Study of Patient With Frequent Exacerbations in MoscowRecruitingNCT07307781
- Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac BiomarkersRecruitingNCT07306949Phase 4
- A Study of AZD0120 in Autoimmune DiseasesRecruitingNCT07295847Phase 1/2
- Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm StudyRecruitingNCT07295821Phase 2
- Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic AlterationsRecruitingNCT07291037Phase 3
- A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy ParticipantsRecruitingNCT07290283Phase 1
- Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in BelarusRecruitingNCT07288515
- Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal AntibodyRecruitingNCT07285213Phase 2
- Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)Not yet recruitingNCT07279948
- Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.RecruitingNCT07279935Phase 4
- A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisRecruitingNCT07276581Phase 2
- Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL AmyloidosisRecruitingNCT07250269Phase 1
- Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in RussiaRecruitingNCT07247279
- Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist DiagnosisRecruitingNCT07245576
- A Study of AZD4063 in PLN R14del Dilated CardiomyopathyRecruitingNCT07241104Phase 1
- Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney DiseaseRecruitingNCT07228364Phase 1
- An Open-label Study of AZD0120 in Adults With Multiple SclerosisRecruitingNCT07224373Phase 1
- A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With RavulizumabRecruitingNCT07221838Phase 4
- Prevalence, Clinical Characteristics, Progression, and Management of Neurofibromatosis Type 1 in Egypt (NF1-Egy)RecruitingNCT07221331
- A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)RecruitingNCT07221253Phase 3
- ALXN2350 in Adult Participants With BAG3-Associated Dilated CardiomyopathyRecruitingNCT07218887Phase 1/2
- AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian CancerRecruitingNCT07218809Phase 3
- A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.RecruitingNCT07215702Phase 2
- AZD0486 1L Therapy for Elderly or Unfit Participants With LBCLRecruitingNCT07215585Phase 3
- A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in ItalyRecruitingNCT07214753
- A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast CancerRecruitingNCT07205822Phase 3
- The Eplontersen Pregnancy and Lactation Outcomes StudyRecruitingNCT07205666
- Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE ParticipantsRecruitingNCT07201558Phase 1
- A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate CancerRecruitingNCT07192614Phase 1/2
- Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerRecruitingNCT07181161Phase 1/2
- A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care TherapyRecruitingNCT07161414Phase 1
- Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in ChinaRecruitingNCT07161388
- Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)RecruitingNCT07157787Phase 2
- Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX OverexpressionRecruitingNCT07155226Phase 1/2
- Observational Study Investigating Demographic and Clinical Characteristics of SLE Patients in EgyptNot yet recruitingNCT07144514
- LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in CanadaRecruitingNCT07143110
- DESTINY-PANTUMOUR04RecruitingNCT07124000
- A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin LymphomaRecruitingNCT07123454Phase 1/2
- A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsRecruitingNCT07115043Phase 1/2
- Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic LeukemiaRecruitingNCT07109219Phase 1/2
- DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First-line Treatment PatternsRecruitingNCT07109154
- GYNGHER - HER2 Expression in Gynecological Malignancies: a Brazilian CohortRecruitingNCT07101081
- A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT07098338Phase 2
- Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsiaRecruitingNCT07088991
- A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa ColonizationRecruitingNCT07088926Phase 2
- A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseRecruitingNCT07082738Phase 2
- A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.RecruitingNCT07081646Phase 1/2
- A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and HyperinflationRecruitingNCT07073950Phase 4
- A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)RecruitingNCT07073547Phase 1
- Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST CancerRecruitingNCT07070128
- Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/TrixeoRecruitingNCT07069829
- A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal AdenocarcinomaRecruitingNCT07069712Phase 2
- A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA RegionRecruitingNCT07065344
- A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)RecruitingNCT07064122Phase 1
- Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDerationRecruitingNCT07052578
- Anifrolumab Pregnancy StudyRecruitingNCT07049653
- Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)RecruitingNCT07044336Phase 3
- An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian FederationRecruitingNCT07041606
- TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian FederationRecruitingNCT07038928
- A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in SpainRecruitingNCT07029737Phase 2
- A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy ParticipantsRecruitingNCT07024823Phase 1
- MAVRiC Studies 2L Treatment With AV in Patients With CLL/SLL Who Have Relapsed After a Course of BTKi + BCL2i Combination, With or Without ObinutuzumabRecruitingNCT07024706Phase 2
- Study of Ravulizumab in Pediatric Participants With Primary IgANRecruitingNCT07024563Phase 3
- A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First EventRecruitingNCT07000357Phase 3
- Anifrolumab Malignancy and Serious Infections StudyRecruitingNCT07000110
- Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in KoreaNot yet recruitingNCT06998095
- A Platform Study in Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT06996782Phase 1/2
- Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing SurveillanceRecruitingNCT06995833
- DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerRecruitingNCT06989112Phase 3
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With DyslipidemiaRecruitingNCT06980428Phase 1
- Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia GravisRecruitingNCT06967480
- Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)RecruitingNCT06960577Phase 2
- A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationRecruitingNCT06952803Phase 3
- A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy VolunteersRecruitingNCT06951880Phase 1
- Tezspire Cardiac Events PASSRecruitingNCT06951867
- Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsRecruitingNCT06932263Phase 2
- CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREARecruitingNCT06927648
- Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaRecruitingNCT06921785Phase 3
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.RecruitingNCT06916806Phase 1
- The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-managementRecruitingNCT06909773Not applicable
- Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia GravisRecruitingNCT06909253
- A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLERecruitingNCT06897930Phase 1/2